Sandra
Hervas Stubbs
Profesional Investigadora
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (15)
2024
-
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates
Gut
2022
-
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
Frontiers in Immunology, Vol. 13
-
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
Frontiers in Immunology, Vol. 13
-
Neoantigens as potential vaccines in hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 2
-
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
International Journal of Molecular Sciences, Vol. 23, Núm. 4
2021
-
Adenovirus-mediated inducible expression of a pd-l1 blocking antibody in combination with macrophage depletion improves survival in a mouse model of peritoneal carcinomatosis
International Journal of Molecular Sciences, Vol. 22, Núm. 8
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
-
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
British Journal of Cancer, Vol. 124, Núm. 6, pp. 1138-1149
2020
-
Inflammation and immunity in ovarian cancer
European Journal of Cancer, Supplement, Vol. 15, pp. 56-66
-
Long-term systemic expression of a novel pd-1 blocking nanobody from an aav vector provides antitumor activity without toxicity
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
2019
-
Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4–induced M2 macrophage polarization
FASEB Journal, Vol. 33, Núm. 6, pp. 7578-7587
2014
-
Anion exchanger 2 is critical for CD8+ T cells to maintain pHi homeostasis and modulate immune responses
European Journal of Immunology, Vol. 44, Núm. 5, pp. 1341-1351
2010
-
Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates
Molecular Therapy, Vol. 18, Núm. 4, pp. 754-765
2009
-
PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector
Gene Therapy, Vol. 16, Núm. 1, pp. 136-141